Net loss Intellia Therapeutics 2014-2023
The net loss for Intellia Therapeutics in 2023 amounted to some 481 million U.S. dollars. The statistic illustrates the net loss for Intellia between 2014 and 2023. Intellia is a biotech company that produces therapeutics using CRISPR technology.